Skip to main content
Home
    • en
    • fr
  • Search form

Main menu

  • About us
    • Our mission
    • Facts & Figures
    • Our Strategy
    • Corporate Governance/ Executive Committee
    • bioMérieux Worldwide
    • Our History
    • Innovation
    • Institut Mérieux

  • Responsibility
    • Our ambition
    • Health
    • Planet
    • Healthcare ecosystem
    • Employees
    • Extended Company
    • SantéRESISTANCE TO ANTIBIOTICS
    • PlanèteCOVID-19 EXCEPTIONAL DONATIONS
  • Solutions
    • Clinical Solutions
    • Industry Solutions
    • Product Quality & Safety
    • Customer Service
    • Cybersecurity
    • Technical Library
    • CLINICAL SOLUTIONS
    • INDUSTRY SOLUTIONS
  • Expertise
    • The importance of diagnostics
      • Clinical diagnostics
      • Industrial Microbiological Control
    • Clinical applications
      • Infectious diseases
      • COVID-19
      • Antimicrobial resistance and Healthcare-associated infections
      • Cardiovascular Emergencies
      • Personalized medicine
    • Industrial applications
      • Agri-food sector
      • Biopharma & cosmetics sectors
    • Our technologies, systems and services
      • Microbiology
      • Molecular Biology
      • Immunoassays
      • Services
    • Glossary of Scientific Terms
  • Education
    • Antimicrobial Resistance / Antimicrobial Stewardship
      • Webinars
      • Educational Materials
      • External Resources
    • Sepsis / Bloodstream Infections
      • Webinars
      • Educational Tutorials
      • Educational Materials
      • External Resources
    • COVID-19
      • Webinars
    • Acute Kidney Injury
      • Webinars & Symposiums
      • Educational Materials
      • External Resources
    • Educational booklets
  • Investors
    • The bioMérieux Share
    • Publications
    • Regulated Information
    • Governance
    • Shareholder area
    • UNIVERSAL REGISTRATION DOCUMENT
    • CORPORATE SOCIAL RESPONSIBILITY
  • Newsroom
    • Press Releases
    • Corporate calendar
    • Media Center
    • About bioMérieux
    • bioMérieux announces the CE marking of 3 dengue immunoessays on VIDAS®
    • PRESS CONTACTS
     
  • Careers
    • Joining bioMérieux
      • Corporate culture
      • Public health mission
      • International presence
      • Professional development
      • Diversity and inclusion
      • Well-being at work
      • Compensation and benefits
    • Job Profiles
      • R&D
      • Manufacturing
      • Supply Chain
      • Information Systems
      • Quality
      • Business
      • Support Functions
      • Medical Affairs
      • HSE
      • Clinical Affairs and Regulatory Affairs
  • Contact us
Home
  • About us
    • Our mission
    • Facts & Figures
    • Our Strategy
    • Corporate Governance/ Executive Committee
    • bioMérieux Worldwide
    • Our History
    • Innovation
    • Institut Mérieux
  • Responsibility
    • Our ambition
    • Health
    • Planet
    • Healthcare ecosystem
    • Employees
    • Extended Company
  • Solutions
    • Clinical Solutions
    • Industry Solutions
    • Product Quality & Safety
    • Customer Service
    • Cybersecurity
    • Technical Library
  • Expertise
    • The importance of diagnostics
    • Clinical applications
    • Industrial applications
    • Our technologies, systems and services
    • Glossary of Scientific Terms
  • Education
    • Antimicrobial Resistance / Antimicrobial Stewardship
    • Sepsis / Bloodstream Infections
    • COVID-19
    • Acute Kidney Injury
    • Educational booklets
  • Investors
    • The bioMérieux Share
    • Publications
    • Regulated Information
    • Governance
    • Shareholder area
  • Newsroom
    • Press Releases
    • Corporate calendar
    • Media Center
    • About bioMérieux
  • Careers
    • Joining bioMérieux
    • Job Profiles
  • Contact us
    • Investor Relations
    • Press Contacts
    • en
    • fr
  • Search form

You are here

Printer-friendly version
  • Home
  • Investors
  • Publications
  • Publications
  • Publications
Investors
  • The bioMérieux Share
    • Stock Market Information
    • Historic Chart
    • Analysts Coverage
    • Analysts Consensus
  • Publications
    • Calendar
    • Press Releases
    • Presentations
    • Annual Reports
    • Universal Registration Documents
  • Regulated Information
  • Governance
    • Regulated Agreements
    • Status
    • Board Charter
  • Shareholder area
    • General Shareholders' Meeting
    • Participating In The General Shareholder's Meeting
    • Dividends
    • Crossing the Thresholds

Publications

Upcoming
Recent
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
Conferences and Roadshows
Results and Shareholder Meetings

No Results for 2003

Contact Us

Contact Us

 

Pioneering diagnostics
  • Legal Notice
  • Privacy
  • Cookie Policy
  • Contact
  • Copyright 2020 bioMérieux SA
  • biomerieux.com
  • bioMérieux Worldwide >
    Discover all our locations
    Asia
    • China (Website)
    • India (Website)
    • Indonesia (website)
    • Japan (Website)
    • Korea
    • Malaysia (website)
    • Philippines (website)
    • Singapore (Website)
    • Thailand (website)
    • Vietnam (website)
    Europe, Middle East, Africa
    • Algeria
    • Austria (Website)
    • Belgium
    • Czech Republic (Website)
    • Denmark (Website)
    • Finland (Website)
    • France (Website)
    • Germany (Website)
    • Greece
    • Hungary (Website)
    • Italy (Website)
    • Ivory Coast
    • Netherlands
    • Norway (Website)
    • Poland (Website)
    • Portugal (Website)
    • Russia (Website)
    • Serbia
    • South Africa (Website)
    • Spain (Website)
    • Sweden (Website)
    • Switzerland (Website)
    • Turkey (Website)
    • United Arab Emirates
    • United Kingdom (Website)
    North America
    • Canada (Website)
    • United States (Website)
    Oceania
    • Australia (Website)
    • New Zealand (Website)
    South America
    • Argentina (Website)
    • Brazil (Website)
    • Chile (Website)
    • Colombia (Website)
    • Mexico (Website)
  • Our Specific Websites >
    • Antimicrobial Resistance Website
    • BioFire Diagnostics
    • bioMérieux Clinical Diagnostics
    • bioMérieux Industry
    • bioMérieux Investors
    • bioMérieux Recruitment
    • bioMérieux Culture Media
  • Our communities >
    • mybiomerieux.com